Next Article in Journal
Toxicity Rank Order (TRO) As a New Approach for Toxicity Prediction by QSAR Models
Previous Article in Journal
Social Support Initiatives That Facilitate Exercise Participation in Community Gyms for People with Disability: A Scoping Review
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Understanding of Cervical Screening Adoption among Female University Students Based on the Precaution Adoption Process Model and Health-Belief Model

1
Department of Nursing, Gangseo University, Seoul 07661, Republic of Korea
2
National Cancer Control Institute, National Cancer Center, Goyang 10408, Republic of Korea
3
College of Nursing, Woosuk University, Wanju 55338, Republic of Korea
4
Graduate School of Cancer Science and Policy, National Cancer Center, Goyang 10408, Republic of Korea
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2023, 20(1), 700; https://doi.org/10.3390/ijerph20010700
Submission received: 25 October 2022 / Revised: 17 December 2022 / Accepted: 22 December 2022 / Published: 30 December 2022

Abstract

:
This study aimed to identify the decisional stages for cervical screening and corresponding cognitive factors in female university students. A cross-sectional study was conducted among Korean female university students aged 20–29 years through an online survey. The main outcome was the decisional stage of cervical screening adoption using the precaution adoption process model. The stages were classified into pre-adoption (the unawareness, unengaged, and undecided stages), adoption (the decided to act and acting stages), and refusal (the decided not to act stage). The cognitive factors in each stage were analyzed using the key concepts of the health-belief model. Cervical screening was defined as a clinical Papanicolaou (Pap) smear performed by a physician in a clinic. The final analysis included 1024 students. Approximately 89.0%, 1.0%, and 10.2% were classified as the pre-adoption, refusal, and adoption stages, respectively. Compared to the pre-adoption stage group, the adoption stage group was more likely to be older and have higher self-efficacy and knowledge. Most participants belonged to the pre-adoption stage—those unaware of cervical screening. Furthermore, most had a low level of knowledge and perception of cervical cancer and its screening. Therefore, our study highlighted the need for education to increase awareness and knowledge of cervical screening in this population.

1. Introduction

Since the Papanicolaou (Pap) smear test is a relatively easy and non-invasive tool for cervical cancer screening; it is generally recommended as a primary test for cervical screening [1,2]. In Korea, approximately 26.0% of young women in their 20s have undergone cervical screening using a Pap smear, which was significantly lower than that in other age groups (56%) [3].
The precaution adoption process model (PAPM) is an important theoretical framework that explains a person’s decision-making process to avoid health threats through precautious behaviors [4]. Compared with the behavior change stage model, the PAPM is more applicable for individuals with low awareness of health behaviors since it adds decisional stages that do not recognize health behavior (Stages 1 and 2, unaware and unengaged by the issue, respectively) and the stage wherein no action was decided upon (Stage 4, decided not to act) [5,6]. Moreover, individuals’ beliefs, self-efficacy, and knowledge influence the movement of the stage towards the adoption of health behaviors [7,8,9]. In the context of cancer-screening participation, PAPM has been used to identify individuals’ decisional stages related to breast [5], colorectal [8,10], and cervical cancer screening [6,7,9,11]. Regarding cervical cancer screening, in a study of UK women who did not participate in cervical cancer screening, 28% of them were unaware of the screening; particularly, young women aged 25–34 years compared with those aged over 35 years were significantly unaware of the screening [6]. The study confirmed that there was a difference in health beliefs at each stage [7]. In a qualitative study, the barriers to participation in cervical cancer screening at each stage of PAPM were evaluated [11].
The health-belief model (HBM) is a theoretical framework that explains and predicts health-related behaviors [12]. The key concepts of the HBM are based on individual beliefs, which consist of perceived susceptibility, severity, benefits, and barriers, and self-efficacy [12]. Previous studies have identified significant differences regarding individual beliefs by HBM that affect cervical screening participation [9,13]. Among the key concepts, self-efficacy is the perception of self-control ability [14]; particularly, a direct relationship has been observed between self-efficacy and the likelihood of undergoing cervical screening [15]. In addition, knowledge is a modifying factor of the HBM and affects individuals’ health beliefs and participation in cervical screening [16]. In an Iranian study, housewife women were more likely to participate in cervical screening as they perceived more benefits and fewer barriers to screening and had higher self-efficacy for undergoing screening [17]. In addition, the determinants of interest in cervical screening participation were perceived threats, benefits, and barriers, and cues for action [18].
Currently, there are only a few studies regarding the non-participation of young women in cervical screening in Korea [19,20]. Therefore, we aimed to identify the decisional stage for cervical screening adoption and cognitive factors associated with each stage among female university students.

2. Materials and Methods

2.1. Study Design and Participants

In Korea, a descriptive and cross-sectional study was conducted between August and September 2015. All participants were recruited through online community sites of four universities located in Seoul, South Korea. This study included female students aged 20–29 years who are attending the university and have no history of cervical cancer. An online survey was conducted for data collection. The study descriptions and written orientations regarding the risks of participating in the study were posted in the online communities of the universities. Participants expressed their consent by ticking the consent box and answering the questionnaire. A total of 1250 participants answered the online questionnaire; however, 226 participants who used the same internet protocol address (IP address) were excluded. Therefore, 1024 participants were included in the final analysis. The study was evaluated by STROBE (strengthening the reporting of observational study cross-sectional study). This study was approved by the Institutional Review Board of the NCC, Korea (IRB No. NCC2015-0066).

2.2. Data Collection and Outcome Measures

Survey items were developed based on a review of previous studies and the theoretical frameworks of the PAPM and HBM. To ensure the content validity of the questionnaire, three specialists in obstetrics and gynecology, laboratory medicine, and preventive medicine, as well as two nursing professors, participated in modifying and confirming the survey items. In our study, cervical screening was defined as a clinical Papanicolaou (Pap) smear performed by a physician in a clinic. To identify the participants’ characteristics, relevant questions were classified into four categories: (1) perception of cervical cancer and screening based on HBM; (2) knowledge regarding cervical cancer and its prevention; (3) the decisional stage of cervical screening adoption based on PAPM; and (4) preference regarding cervical sampling (clinician-sampled Pap smear) or vaginal sampling (self-sampled human papilloma virus (HPV) test).
The perception of cervical cancer and screening based on HBM consisted of five subscales: perceived susceptibility, perceived severity, perceived benefits, perceived barriers, and self-efficacy regarding cervical cancer. Additionally, the screening was measured using the champion health-belief model scale [21]; on the other hand, self-efficacy was measured through the replacement of breast cancer with cervical cancer [22]. Among the items of the perceived barrier subscale, one item was deleted (I feel uncomfortable talking about cervical cancer) due to its inappropriateness for young women with less exposure to cancer. Furthermore, two items were added based on previous research [23]: ‘I prefer a female doctor to conduct a cervical screening’ and ‘There is no health care center close to my house to have a cervical screening’. Regarding the self-efficacy items, two items were excluded that were related to the arrangement of transportation and of knowledge of cervical screening procedures. This study was conducted in a large city; therefore, the means of transportation were abundant. The other item was related to knowledge instead of to self-efficacy. All of the items (perceived susceptibility (5 items, Cronbach’s alpha = 0.862), perceived severity (7 items, Cronbach’s alpha = 0.830), perceived benefits (6 items, Cronbach’s alpha = 0.916), perceived barriers (7 items, Cronbach’s alpha = 0.734), and self-efficacy (8 items, Cronbach’s alpha = 0.863)) were rated on a five-point Likert scale ranging from strongly disagree to strongly agree.
Knowledge about cervical cancer was measured using 11 items (four items for risk factors; two for symptoms; two for prevention; and three for epidemiology and treatment). The items on risk factors consisted of questions about the relationship between HPV infections, transmission through sexual intercourse, sexual intercourse at an early age, smoking, and ‘cervical cancer’. Regarding symptoms, items about early and late symptoms of cervical cancer were included. Considering prevention, items about preventable cervical cancer and participation in the Pap smear in sexually experienced women were included. Questions about epidemiology and treatment included the incidence rate of cervical cancer, the importance of early detection, and HPV vaccination. Each item could be scored as 1 for correct responses or 0 for incorrect or ‘I don’t know’ responses. The possible scores ranged from 0 (poor knowledge) to 11 (high knowledge). Cronbach’s alpha for the knowledge scale was 0.863.
PAPM was used to measure the decisional stage of cervical screening adoption [4]. Stage 7 (maintaining up-to-date screening status) of PAPM was not considered, due to the low age of the sample, which might decrease the need to undergo regular check-ups for cancer. The stages were classified into three groups: (1) The pre-adoption stage group, which included stages 1 (unawareness; uninformed regarding cervical screening), 2 (unengaged; aware of cervical screening but has not provided serious thoughts regarding screening), and 3 (undecided; considered but has not decided to undergo cervical screening); (2) The refusal stage group, which included stage 4 (decided not to act; decided to undergo cervical screening); and (3) The adoption stage group, which included stages 5 (decided to act; decided to undergo cervical screening) and stage 6 (acting; underwent cervical screening). To evaluate the preference between cervical (clinician-sampled Pap smear) and vaginal sampling (self-sampled HPV test), explanations regarding the two methods are presented with images of vaginal sampling.

2.3. Statistical Analysis

All statistical analyses were performed using SPSS version 25.0 software (IBM Corp., Armonk, NY, USA). Differences between groups were analyzed by Student’s t-test or χ2 test. Statistical significance was set at p < 0.05. Logistic regression analysis was conducted to identify the associations between potential factors and the decisional stages of cervical screening adoption of PAPM.

3. Results

3.1. General Characteristics and Decisional Stage of Cervical Screening Adoption

The general characteristics of the participants are shown in Table 1. A total of 1024 participants were included in the study, with a mean age of 22.65 ± 2.48 years. Among them, 89.0% were classified into the pre-adoption stage (unawareness, 68.8%; unengaged, 6.3%; and undecided, 13.9%). On the other hand, 10.2% were classified into the adoption stage, among whom 5.4% (decide to act) of the participants decided to undergo cervical screening and 4.8% (acting) had undergone cervical screening.
In the refusal stage (decided not to act), only 1.0% of participants decided not to undergo cervical screening. Table 1 shows the distribution of participants by stage based on the PAPM.

3.2. Factors Related to Decisional Stage of Cervical Screening Adoption

The characteristics of the study participants according to the decisional stages of cervical screening adoption based on PAPM and HBM are presented in Table 2. Few participants (n = 10) decided against undergoing cervical screening (stage 4); therefore, they were excluded from the bivariate analysis. Multiple logistic regression analysis was conducted to identify factors associated with the decisional stages of cervical screening adoption. The adoption stage group was significantly older (adjusted odds ratio (aOR): 1.13, 95% confidence interval (CI): 1.03 to 1.23), had higher self-efficacy (aOR: 1.13, 95% CI: 1.07 to 1.20), and had higher knowledge (aOR: 1.36, 95% CI: 1.23 1.51) compared with the pre-adoption stage group.

3.3. Preference of Cervical Screening Method

To identify the preferred screening methods for each stage group, data were analyzed using the χ2 test. Compared with the adoption stage group, participants in the pre-adoption stage preferred vaginal sampling when performing cervical screening (χ2: 7.84, p < 0.01) (Figure 1).

4. Discussion

This study identified the decisional stages of cervical screening adoption and factors associated with the stages of PAPM and HBM in female university students. Most participants were classified into the pre-adoption stage; on the other hand, approximately, only 10.0% were included in the adoption stage. Participants in the adoption stage had an increased likelihood of having higher knowledge of cervical cancer and screening and had higher self-efficacy for receiving cervical screening than those in the pre-adoption stage.
Based on the PAPM, our study confirmed that most participants were in the pre-adoption stage (stages 1-3) of cervical screening. In particular, 68.8% of the participants had no knowledge or were unaware of cervical screening (stage 1); this is consistent with the study of Kim [20] in Korean female university students. On the other hand, 4.8% of participants in our study received cervical screening, which was significantly lower than the 20.9% and 54.7% cervical screening rate of women in their 20s in Korea and Japan, respectively [3,24]; furthermore, approximately 68.0% of sexually active university students in the United States have received cervical screening [25]. The Korean Guideline for cervical cancer screening recommends a Pap smear every 3 years in women aged 20–74 years [1]. Since 2016, the National Cancer Screening Program has been providing cervical cancer screening using a Pap smear every two years in women over the age of 20 [1]. Nevertheless, as a result of analyzing trends in cervical cancer incidence and mortality in Korea over the past 20 years, it has significantly increased only in young women in their 20s [26]. Therefore, active community-based efforts are necessary for encouraging young women to participate more in cervical cancer screening.
Regarding cognitive factors for the decisional stages of cervical screening adoption based on HBM, the adoption stage group showed higher self-efficacy than the pre-adoption stage. In cancer screening, self-efficacy is an important determinant of the screening rate [15], which predicts the decisional stage progression for cervical screening [16]. In South Africa, a previous study reported that female university students who underwent cervical screening had significantly higher levels of self-efficacy than those who had not undergone cervical screening [27]. Moreover, a high level of self-efficacy for human papillomavirus (HPV) vaccination and sexual health behaviors with condom use was related to increased intention of HPV vaccination and condom usage among university students [28]. However, we found that an individual’s belief of HBM, except self-efficacy, was slightly higher in the adoption stage group than in the pre-adoption stage, but the difference was not significant. In particular, low perceived susceptibility for cervical cancer was evident in both stages, which may be attributed to misconceptions regarding cervical cancer caused by a lack of knowledge and awareness in young women (i.e., they are healthy or they are not at risk of cervical cancer) [20,24].
Additionally, knowledge is a modifying factor of HBM that influences individual beliefs and health behaviors [16]. In our findings, knowledge of cervical cancer and prevention was significantly higher in participants in the adoption stage compared than in those in the pre-adoption stage. However, most participants were classified as the pre-adoption stage; therefore, there was a greater number of participants who had an unsatisfactory level of knowledge regarding cervical cancer and prevention. This finding is consistent with previous studies in different countries. In India, a survey of female university students found that approximately 98.0% of participants were unaware of cervical screening, and approximately 95.0% were uninformed regarding the risk factors of cervical cancer [29]; studies in Malaysia and UK showed similar results [30,31].
Previous studies have shown that HBM-based educational interventions increased the screening rate [32]; furthermore, the strategies for each decisional stage of cervical screening adoption using a behavioral stage change model yielded positive results in women of all ages [9,33]. These educational interventions were similarly effective in enhancing cervical screening rate in female university students [34]. Therefore, we suggest the use of HBM-based educational interventions to improve the knowledge and beliefs of female university students regarding cervical screening. In addition, we found that participants in the pre-adoption stage preferred vaginal sampling (self-sampled HPV test) compared to cervical sampling (clinician-sampled Pap smear). Therefore, the approach of using vaginal sampling could be considered to be an effective method to engage non-participants [35].
This study has several limitations. First, this was a cross-sectional study that did not establish a clear and causal relationship between antecedent and consequent factors. Second, the sexual activity of the participants were not evaluated. Kim [36] reported that the sexual experience of female university students was approximately 60.0%, which indicates a high possibility that participants with no sexual experience were included. Therefore, in our study, the number of participants in the adoption stage of cervical screening would have been lower. Nevertheless, our study focused on the population with the lowest cervical screening rate among the screening target age groups: female university students in their early 20s. Furthermore, it was the first to identify the decision stages of the cervical screening adoption and cognitive factors according to stage. Therefore, our findings could contribute to the establishment of interventions for improving cervical screening by providing an in-depth understanding of behaviors related to screening among young women.

5. Conclusions

In conclusion, our study confirmed that most female university students belonged to the pre-adoption stage: those who were not aware of cervical screening and rarely underwent screening. Moreover, participants in the pre-adoption stage were less likely to have lower knowledge and self-efficacy than those in the adoption stage. Therefore, our findings highlight the need for a decisional stage-based educational approach to increase cervical screening adoption among female university students.

Author Contributions

Conceptualization, J.K.J.; data analysis and writing, H.Y.S. and P.K.; and writing review and editing, J.K.J. and S.Y.S. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (No. 2021R1A2C200686311). Funding bodies played no role in the study design, study setting, analysis, or writing of the manuscript.

Institutional Review Board Statement

This study was carried out under the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board of the National Cancer Center, Korea (NCCNCS-12-683).

Informed Consent Statement

Informed consent was obtained from all subjects.

Data Availability Statement

The dataset supporting the conclusions of this article is available from the corresponding author on reasonable request.

Conflicts of Interest

The authors declare that they have no competing interests to declare.

References

  1. Min, K.-J.; Lee, Y.J.; Suh, M.; Yoo, C.W.; Lim, M.C.; Choi, J.; Ki, M.; Kim, Y.-M.; Kim, J.-W.; Kim, J.-H. The Korean guideline for cervical cancer screening. J. Ggynecol. Oncol. 2015, 26, 232–239. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Jun, J.K.; Choi, K.S.; Jung, K.W.; Lee, H.Y.; Gapstur, S.M.; Park, E.C.; Yoo, K.Y. Effectiveness of an organized cervical cancer screening program in Korea: Results from a cohort study. Int. J. Cancer. 2009, 124, 188–193. [Google Scholar] [CrossRef] [PubMed]
  3. Shin, H.Y.; Lee, Y.Y.; Song, S.Y.; Park, B.; Suh, M.; Choi, K.S.; Jun, J.K. Trends in cervical cancer screening rates among Korean women: Results of the Korean National Cancer Screening Survey, 2005–2020. J. Ggynecol. Oncol. 2022, 33, e39. [Google Scholar] [CrossRef] [PubMed]
  4. De Vet, E.; de Nooijer, J.; Oenema, A.; de Vries, N.K.; Brug, J. Predictors of stage transitions in the precaution adoption process model. Am. J. Health Promot. 2008, 22, 282–290. [Google Scholar] [CrossRef]
  5. Jin, S.W.; Lee, J.; Yun Lee, H. Analyzing factors associated with decisional stage of adopting breast cancer screening among Korean American women using precaution adoption process model. Ethn. Health 2021, 3, 431–447. [Google Scholar] [CrossRef]
  6. Marlow, L.A.; Chorley, A.J.; Haddrell, J.; Ferrer, R.; Waller, J. Understanding the heterogeneity of cervical cancer screening non-participants: Data from a national sample of British women. Eur. J. Cancer. 2017, 80, 30–38. [Google Scholar] [CrossRef] [Green Version]
  7. Marlow, L.A.; Ferrer, R.A.; Chorley, A.J.; Haddrell, J.B.; Waller, J. Variation in health beliefs across different types of cervical screening non-participants. Prev. Med. 2018, 111, 204–209. [Google Scholar] [CrossRef]
  8. Jin, S.W.; Lee, J.; Lee, S. Analyzing factors associated with decisional stage of adoption for colorectal cancer screening among older Korean Americans using precaution adoption process model. J. Transcult. Nurs. 2019, 30, 461–470. [Google Scholar] [CrossRef]
  9. Bahmani, A.; Mahmoodabad, S.; Enjezab, B.; Askarshahi, M.; Baghianimoghadam, M. The Effect of Training Based on Precaution Adoption Process Model (PAPM) on Rural Females’ Participation in Pap smear. J. Pharm. Res. Int. 2017, 16, 1–7. [Google Scholar] [CrossRef]
  10. Hester, C.; Born, W.; Yeh, H.; Young, K.L.; James, A.S.; Daley, C.M.; Greiner, K.A. Decisional stage distribution for colorectal cancer screening among diverse, low-income study participants. Health Educ. Res. 2015, 30, 400–411. [Google Scholar] [CrossRef]
  11. Marlow, L.A.; Chorley, A.J.; Rockliffe, L.; Waller, J. Decision-making about cervical screening in a heterogeneous sample of nonparticipants: A qualitative interview study. Psycho-Onco. 2018, 27, 2488–2493. [Google Scholar] [CrossRef] [PubMed]
  12. Champion, V.L.; Skinner, C.S. The Health-belief model. In Health Behaviour and Health Education: Theory, Research, and Practice; Jossey-Bass: San Francisco, CA, USA, 2008; pp. 45–65. [Google Scholar]
  13. Aldohaian, A.I.; Alshammari, S.A.; Arafah, D.M. Using the health-belief model to assess beliefs and behaviors regarding cervical cancer screening among Saudi women: A cross-sectional observational study. BMC Womens Health 2019, 19, 1–12. [Google Scholar] [CrossRef] [PubMed]
  14. Carpenter, V.; Colwell, B. Cancer knowledge, self-efficacy, and cancer screening behaviors among Mexican-American women. J. Cancer Educ. 1995, 10, 217–222. [Google Scholar] [PubMed]
  15. Bunkarn, O.; Kusol, K.; Eksirinimit, T. The Outcome of a Self-Efficacy Enhancement Program for Cervical Cancer Screening among Women in Phrasaeng District, Suratthani Province, Thailand. Asian Pac. J. Cancer Prev. 2020, 21, 2075–2081. [Google Scholar] [CrossRef]
  16. Miri, M.R.; Moodi, M.; Sharif-Zadeh, G.-R.; Malaki Moghadam, H.; Miri, M.; Norozi, E. Cognitive predictors of cervical cancer screening’s stages of change among sample of Iranian women health volunteers: A path analysis. PLoS ONE 2018, 13, e0193638. [Google Scholar] [CrossRef] [Green Version]
  17. Babazadeh, T.; Nadrian, H.; Rezakhani Moghaddam, H.; Ezzati, E.; Sarkhosh, R.; Aghemiri, S. Cognitive determinants of cervical cancer screening behavior among housewife women in Iran: An application of Health-belief model. Health Care Women Int. 2018, 39, 555–570. [Google Scholar] [CrossRef]
  18. Ampofo, A.G.; Adumatta, A.D.; Owusu, E.; Awuviry-Newton, K. A cross-sectional study of barriers to cervical cancer screening uptake in Ghana: An application of the health-belief model. PLoS ONE 2020, 15, e0231459. [Google Scholar] [CrossRef]
  19. Shin, H.Y.; Song, S.Y.; Jun, J.K.; Kim, K.Y.; Kang, P. Barriers and strategies for cervical cancer screening: What do female university students know and want? PLoS ONE 2021, 16, e0257529. [Google Scholar] [CrossRef]
  20. Kim, H.W. Awareness of Pap testing and factors associated with intent to undergo Pap testing by level of sexual experience in unmarried university students in Korea: Results from an online survey. BMC Womens Health 2014, 14, 100. [Google Scholar] [CrossRef] [Green Version]
  21. Champion, V.L. Instrument development for health-belief model constructs. Adv. Nurs. Sci. 1984, 6, 73–85. [Google Scholar] [CrossRef]
  22. Champion, V.; Skinner, C.S.; Menon, U. Development of a self-efficacy scale for mammography. Res. Nurs. Health. 2005, 28, 329–336. [Google Scholar] [CrossRef] [PubMed]
  23. Guvenc, G.; Akyuz, A.; Açikel, C.H. Health-belief model scale for cervical cancer and Pap smear test: Psychometric testing. J. Adv. Nurs. 2011, 67, 428–437. [Google Scholar] [CrossRef] [PubMed]
  24. Kaneko, N. Factors associated with cervical cancer screening among young unmarried Japanese women: Results from an internet-based survey. BMC Womens Health 2018, 18, 132. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Wilson, K.L.; Cowart, C.J.; Rosen, B.L.; Pulczinski, J.C.; Solari, K.D.; Ory, M.G.; Smith, M.L. Characteristics Associated with HPV Diagnosis and Perceived Risk for Cervical Cancer Among Unmarried, Sexually Active College Women. J. Cancer. Educ. 2018, 33, 404–416. [Google Scholar] [CrossRef]
  26. Moon, E.-K.; Oh, C.-M.; Won, Y.-J.; Lee, J.-K.; Jung, K.-W.; Cho, H.; Jun, J.K.; Lim, M.C.; Ki, M. Trends and age-period-cohort effects on the incidence and mortality rate of cervical cancer in Korea. Cancer Res. Treat. 2017, 49, 526–533. [Google Scholar] [CrossRef] [Green Version]
  27. Hoque, M.E.; Ghuman, S.; Coopoosmay, R.; van Hal, G. Cervical cancer screening among university students in South Africa: A theory-based study. PLoS ONE 2014, 9, e111557. [Google Scholar] [CrossRef] [Green Version]
  28. Stout, M.E.; Christy, S.M.; Winger, J.G.; Vadaparampil, S.T.; Mosher, C.E. Self-efficacy and HPV vaccine attitudes mediate the relationship between social norms and intentions to receive the HPV vaccine among college students. J. Commun. Health 2020, 45, 1187–1195. [Google Scholar] [CrossRef]
  29. Manikandan, S.; Behera, S.; Naidu, N.M.; Angamuthu, V.; Mohammed, O.F.B.; Debata, A. Knowledge and awareness toward cervical cancer screening and prevention among the professional college female students. J. Pharm. Bioallied Sci. 2019, 11 (Suppl. 2), S314–S320. [Google Scholar] [CrossRef]
  30. Ali, A.; Kar Mun, L.; Prajapati, S.; Zahid Iqbal, M.; Zulfikar Ahmed, N. Cervical cancer, its screening and vaccination: A KAP study among female healthcare students in a Private University, Malaysia. MOJ Bioequival. Bioavail. 2018, 5, 275–282. [Google Scholar] [CrossRef]
  31. Ogbonna, F.S. Knowledge, attitude, and experience of cervical cancer and screening among Sub-saharan African female students in a UK University. Ann. Afr. Med. 2017, 16, 18–23. [Google Scholar] [CrossRef]
  32. Brevik, T.B.; Laake, P.; Bjørkly, S. Effect of culturally tailored education on attendance at mammography and the Papanicolaou test. Health Serv. Res. 2020, 55, 457–468. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Krok-Schoen, J.L.; Oliveri, J.M.; Young, G.S.; Katz, M.L.; Tatum, C.M.; Paskett, E.D. Evaluating the stage of change model to a cervical cancer screening intervention among Ohio Appalachian women. Women Health 2016, 56, 468–486. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Staples, J.N.; Wong, M.S.; Rimel, B. An educational intervention to improve human papilloma virus (HPV) and cervical cancer knowledge among African American college students. Gynecol. Oncol. 2018, 149, 101–105. [Google Scholar] [CrossRef] [PubMed]
  35. Kitchener, H.; Gittins, M.; Cruickshank, M.; Moseley, C.; Fletcher, S.; Albrow, R.; Gray, A.; Brabin, L.; Torgerson, D.; Crosbie, E.J.; et al. A cluster randomized trial of strategies to increase uptake amongst young women invited for their first cervical screen: The STRATEGIC trial. J. Med. Screen. 2018, 25, 88–98. [Google Scholar] [CrossRef] [Green Version]
  36. Kim, J. Analysis of sexual related predicting factors for female university students in Korea. J. Converg. Cult. Technol. 2015, 1, 15–26. [Google Scholar] [CrossRef]
Figure 1. Preference in terms of screening methods according to the decisional stage of cervical screening adoption. The pre-adoption stage group, which included stages 1 (unawareness), 2 (unengaged), and 3 (undecided); and the adoption stage group, which included stages 5 (decided to act) and stage 6 (acting).
Figure 1. Preference in terms of screening methods according to the decisional stage of cervical screening adoption. The pre-adoption stage group, which included stages 1 (unawareness), 2 (unengaged), and 3 (undecided); and the adoption stage group, which included stages 5 (decided to act) and stage 6 (acting).
Ijerph 20 00700 g001
Table 1. General characteristics of participants.
Table 1. General characteristics of participants.
CharacteristicsTotal (n = 1024)
Age, mean (SD)22.65 (2.48)
Health behavior model, mean (SD)
Perceived susceptibility (range 5–25)11.46 (3.33)
Perceived severity (range 7–35)19.80 (4.67)
Perceived benefits (range 6–30)23.91 (3.63)
Perceived barriers (range 7–35)21.80 (4.23)
Self-efficacy (range 8–40)32.60 (5.16)
Knowledge (range 0–11), mean (SD)6.40 (2.60)
Family history for cervical cancer, n (%)
No960 (93.8)
Yes64 (6.3)
Gynecological treatment in the past, n (%)
No856 (83.6)
Yes168 (16.4)
Smoking, n (%)
No968 (94.5)
Yes or Ever56 (5.5)
Drinking, n (%)
No316 (30.9)
Yes708 (69.1)
HPV vaccination, n (%)
No627 (61.2)
Yes397 (38.8)
Decisional stage based on PAPM, n (%)
Pre-adoption stageUnawareness (stage 1)704 (68.8)
Unengaged (stage 2)64 (6.3)
Undecided (stage 3)142 (13.9)
Refusal stageDecided not to act (stage 4)10 (1.0)
Adoption stageDecided to act (stage 5)55 (5.4)
Acting (stage 6)49 (4.8)
Abbreviations: HPV, human papillomavirus; SD, standard deviation; and PAPM, precaution adoption process model.
Table 2. Associated factors related to decisional stages of cervical screening adoption based on PAPM stage.
Table 2. Associated factors related to decisional stages of cervical screening adoption based on PAPM stage.
CharacteristicsPre-AdoptionAdoptionp-
Value
Adoption vs.
Pre-Adoption
Adoption vs.
Pre-Adoption
n = 910n = 104cOR(95% CI)aOR(95% CI)
Age, mean (SD)22.53 (2.42)23.60 (2.70)<0.0011.18(1.09–1.28)1.13(1.03–1.23)
Health behavior model,
mean (SD)
Perceived susceptibility
(range 5–25)
11.42 (3.29)11.85 (3.57)0.2191.04(0.98–1.10)1.05(0.97–1.12)
Perceived severity
(range 7–35)
19.80 (4.56)20.04 (5.40)0.6671.01(0.97–1.06)1.00(0.95–1.06)
Perceived benefits
(range 6–30)
23.87 (3.60)24.46 (3.73)0.1211.05(0.99–1.11)0.93(0.86–1.01)
Perceived barriers
(range 7–35)
21.97 (4.15)20.55 (4.66)0.0010.93(0.88-0.97)0.96(0.90-1.02)
Self-efficacy (range 8-40),32.29 (5.01)35.61 (5.20)<0.0011.16(1.11-1.21)1.13(1.07-1.20)
Knowledge (range 0–11),
mean (SD)
6.18 (2.56)8.25 (2.13)<0.0011.43(1.30–1.57)1.36(1.23–1.51)
Family history for cervical cancer, n (%)
No860 (94.5)92 (88.5)0.0151.00 (Reference)1.00 (Reference)
Yes50 (5.5)12 (11.5) 2.24(1.15–4.37)1.60(0.77–3.33)
Gynecological treatment in the past,
n (%)
No 770 (84.6)79 (76.0)0.0241.00 (Reference)1.00 (Reference)
Yes 140 (15.4)25 (24.0) 1.74(1.07–2.83)1.47(0.86–2.49)
Smoking, n (%)
No862 (94.7)97 (93.3)0.5351.00 (Reference)1.00 (Reference)
Yes or Ever 48 (5.3)7 (6.7) 1.30(0.57–2.94)1.56(0.65–3.78)
Drinking, n (%)
No278 (30.5)35 (33.7)0.5161.00 (Reference)1.00 (Reference)
Yes632 (69.5)69 (66.3) 0.87(0.56–1.33)0.96(0.59–1.54)
HPV vaccination, n (%)
No 564 (62.0)56 (53.8)0.1071.00 (Reference)1.00 (Reference)
Yes 346 (38.0)48 (46.2) 1.40(0.93–2.10)0.88(0.56–1.38)
Abbreviations: aOR, adjusted odds ratio; CI, confidence interval; cOR, crude odds ratio; HPV, human papillomavirus; SD, standard deviation; and PAPM, precaution adoption process model. The pre-adoption stage included participants who were unaware (stage 1), unengaged (stage 2), and undecided stage (stage 3); the adoption stage included the participants who decided to act (stage 5) and those who were acting (stage 6).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Shin, H.Y.; Kang, P.; Song, S.Y.; Jun, J.K. Understanding of Cervical Screening Adoption among Female University Students Based on the Precaution Adoption Process Model and Health-Belief Model. Int. J. Environ. Res. Public Health 2023, 20, 700. https://doi.org/10.3390/ijerph20010700

AMA Style

Shin HY, Kang P, Song SY, Jun JK. Understanding of Cervical Screening Adoption among Female University Students Based on the Precaution Adoption Process Model and Health-Belief Model. International Journal of Environmental Research and Public Health. 2023; 20(1):700. https://doi.org/10.3390/ijerph20010700

Chicago/Turabian Style

Shin, Hye Young, Purum Kang, Soo Yeon Song, and Jae Kwan Jun. 2023. "Understanding of Cervical Screening Adoption among Female University Students Based on the Precaution Adoption Process Model and Health-Belief Model" International Journal of Environmental Research and Public Health 20, no. 1: 700. https://doi.org/10.3390/ijerph20010700

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop